• Naftifine HCl: Designing Mechanism-First Assays

  2026-09-21

  Naftifine HCl is an allylamine antifungal agent whose defined sterol-biosynthesis target supports rigorous, mechanism-first assay design. This article connects fungal target engagement with practical lessons from WNT5a/GSK3/β-catenin research while clearly separating validated pharmacology from exploratory cross-domain hypotheses.

• Protease Inhibitor Cocktail for cGAS Assays

  2026-09-21

  Protect fragile cGAS-pathway proteins during extraction, Western blotting, co-immunoprecipitation, and kinase analysis with an EDTA-free formulation. The 200X DMSO stock preserves compatibility with divalent-cation-dependent assays while broad inhibitor coverage helps limit ex vivo protein degradation.

• Bromodomain Inhibitor, (+)-JQ1: Bench Workflows

  2026-09-20

  Build more informative BET experiments with (+)-JQ1 by separating growth arrest from true cell killing, then extend the workflow to BRD4, inflammatory signaling, and BRDT research. Practical formulation, timing, and troubleshooting guidance helps turn a dose-response experiment into a mechanistically interpretable assay.

• REV1–DHX36 Control of G-Quadruplex Tolerance

  2026-09-19

  A 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. The findings provide a mechanistic framework for understanding how G4 stabilization activates genome-damage signaling and creates vulnerabilities relevant to cancer research.

• Midecamycin: Practical Antibacterial Assay Workflows

  2026-09-18

  Midecamycin is an acetoxy-substituted macrolide antibiotic for structured in vitro profiling of susceptible Gram-positive organisms, with built-in value as a resistance and assay-control compound. This guide translates published MIC methods into practical stock preparation, screening, MBC confirmation, glycosylation studies, and troubleshooting workflows.

• Thymoquinone Workflows for Cardiotoxicity

  2026-09-18

  Build mechanism-resolved doxorubicin cardiotoxicity studies with Thymoquinone, linking cardiac function to oxidative stress, ferroptosis, and mitochondrial injury. This workflow separates literature-matched mouse dosing from practical formulation, cell-assay optimization, and troubleshooting decisions.

• Psoralen, Isopsoralen, and ERK1/2 Cholestasis

  2026-09-17

  A 2024 Chemical Research in Toxicology study identified ERK1/2 activation as a mechanistic link between the phytoestrogens psoralen and isopsoralen and cholestatic liver injury in zebrafish larvae. By combining estrogen-response measurements, bile-acid gene profiling, phosphorylation analysis, and pharmacological rescue, the work positions ERK1/2 as a testable target in phytoestrogen-associated cholestasis research.

• Biotin-HPDP: Mapping Cysteine Signaling

  2026-09-17

  Biotin-HPDP enables reversible thiol-specific protein labeling for affinity capture, redox analysis, and modification studies. This guide explains how to interpret Biotin-HPDP data in the context of GSDMD palmitoylation and functional pyroptosis assays.

• CD44 Metabolic Rewiring in IDH-Mutant Leukemia

  2026-09-16

  The reference study identifies CD44 as a functional metabolic dependency in IDH-mutant leukemia, linking pentose phosphate pathway activity and NADPH production to sustained R-2HG synthesis. Its isogenic CRISPR design supports a mechanistic rationale for combining mutant-IDH inhibition with CD44 blockade in acute myeloid leukemia research, while also highlighting important limitations for clinical translation.

• Acetylspiramycin: Translating Ribosome Biology

  2026-09-16

  Acetylspiramycin, or Spiramycin B, is a mechanistically defined macrolide tool for connecting 50S ribosomal inhibition with susceptibility testing, resistance analysis, and host-response research. This translational perspective also shows how a refractory ocular infection case can sharpen—not overextend—interpretation of antimicrobial evidence.

• Dimetridazole Restores Cefotaxime Activity in MDR E. coli

  2026-09-15

  A 2025 Scientific Reports study shows that Dimetridazole can potentiate cefotaxime against multidrug-resistant E. coli through coordinated disruption of membrane integrity, permeability, and fatty acid biosynthesis. The work combines checkerboard synergy testing, membrane imaging, lipid analysis, gene-expression measurements, and a Galleria mellonella infection model to connect antibacterial activity with a plausible membrane-centered mechanism.

• EdU Imaging Kits (HF594): Practical Guide

  2026-09-15

  EdU Imaging Kits (HF594) provide a practical endpoint assay for measuring S-phase DNA synthesis in cultured cells by fluorescent click chemistry. They are suited to fluorescence microscopy and flow cytometry, but not to live-cell longitudinal tracking or workflows that require copper-free detection or completely unmodified native DNA.

• Psoralen Cholestasis and ERK1/2 Activation

  2026-09-14

  A 2024 Chemical Research in Toxicology study linked psoralen- and isopsoralen-induced cholestatic liver injury in zebrafish larvae to estrogen-like signaling, altered bile-acid regulation, and ERK1/2 activation. Its combination of functional liver phenotyping, gene-expression analysis, and pharmacological rescue positions ERK1/2 as a mechanistically testable target in phytoestrogen-associated cholestasis.

• Bestatin Dissects Jasmonate Signaling in Arabidopsis

  2026-09-14

  The reference study established bestatin as a chemical-genetic probe that activates jasmonate responses through a COI1-dependent mechanism while not requiring jasmonate biosynthesis in a strictly direct manner. By combining transcript profiling, developmental assays, and screening of bestatin-resistant mutants, the authors identified genetic classes and candidate loci that broaden experimental access to jasmonate signaling.

• Hexamethonium Bromide: Mapping Autonomic Control

  2026-09-13

  Hexamethonium Bromide enables mechanistic analysis of ganglionic control in cardiovascular and neuronal signaling experiments. This article explains how to use blockade results as causal evidence rather than treating them as a standalone blood-pressure endpoint.

8197 records 1/547 page Next 12345 下5页 Last page